GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 348 filers reported holding GUARDANT HEALTH INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,556,089 | -19.2% | 119,976 | -2.4% | 0.00% | -25.0% |
| Q2 2023 | $4,402,541 | +3.7% | 122,976 | -32.1% | 0.00% | 0.0% |
| Q1 2023 | $4,243,671 | -22.8% | 181,044 | -10.4% | 0.00% | -20.0% |
| Q4 2022 | $5,495,597 | -55.4% | 202,044 | -11.8% | 0.01% | -58.3% |
| Q3 2022 | $12,329,000 | +33.4% | 229,044 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $9,240,000 | -32.8% | 229,044 | +10.3% | 0.01% | -20.0% |
| Q1 2022 | $13,749,000 | -30.1% | 207,568 | +5.6% | 0.01% | -28.6% |
| Q4 2021 | $19,669,000 | -20.0% | 196,652 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $24,583,000 | +40.4% | 196,652 | +39.5% | 0.02% | +41.7% |
| Q2 2021 | $17,505,000 | -18.6% | 140,952 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $21,516,000 | +30.4% | 140,952 | +10.1% | 0.02% | +25.0% |
| Q4 2020 | $16,503,000 | +4175.4% | 128,052 | +3611.7% | 0.01% | – |
| Q3 2020 | $386,000 | – | 3,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |